TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/29/25 19:21 | 10/27/25 | HOWL | Werewolf Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gadicke Ansbert | MA | T | S.m | -446 | 1.62 | 0 | -276 | -4 | 6,443 | I | |||||||||||||||
5/15/25 17:34 | 5/13/25 | ITOS | Iteos Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gadicke Ansbert | MA | H | Former 1 | S | -8,317 | 8.06 | 0 | -1,032 | -23 | 3,453 | I | ||||||||||||||
4/30/25 16:08 | 3/27/25 | HOWL | Werewolf Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Gadicke Ansbert | MA | T | S.d | -5 | 1.05 | 0 | -4 | 0 | 6,719 | I | |||||||||||||||
5/24/23 16:38 | 5/22/23 | TCRR | Tcr2 Therapeutics Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Gadicke Ansbert | MA | DT | S.d | -132 | 1.88 | 0 | -70 | -1 | 7,530 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |